Molecular Biomarkers in Bladder Cancer: Novel Potential Indicators of Prognosis and Treatment Outcomes
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular Biomarkers in Bladder Cancer: Novel Potential Indicators of Prognosis and Treatment Outcomes
Authors
Keywords
-
Journal
DISEASE MARKERS
Volume 2016, Issue -, Pages 1-5
Publisher
Hindawi Limited
Online
2016-01-27
DOI
10.1155/2016/8205836
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The mutational spectrum of HRAS, KRAS, NRAS and FGFR3 genes in bladder cancer
- (2017) Slah Ouerhani et al. Cancer Biomarkers
- Exosomal microRNAs as Potential Biomarkers in Castration-resistant Prostate Cancer
- (2015) Benedikta S. Haflidadóttir et al. EUROPEAN UROLOGY
- Exosomal miR-1290 and miR-375 as Prognostic Markers in Castration-resistant Prostate Cancer
- (2015) Xiaoyi Huang et al. EUROPEAN UROLOGY
- Genomic Characterization of Upper Tract Urothelial Carcinoma
- (2015) John P. Sfakianos et al. EUROPEAN UROLOGY
- Downregulation of urinary cell-free microRNA-214 as a diagnostic and prognostic biomarker in bladder cancer
- (2015) Jinfeng Wang et al. JOURNAL OF SURGICAL ONCOLOGY
- Circulating Tumor Cells as Potential Biomarkers in Bladder Cancer
- (2015) Ajjai Alva et al. JOURNAL OF UROLOGY
- Direct quantitative detection for cell-free miR-155 in urine: a potential role in diagnosis and prognosis for non-muscle invasive bladder cancer
- (2015) Xin Zhang et al. Oncotarget
- Circulating miR-497 and miR-663b in plasma are potential novel biomarkers for bladder cancer
- (2015) Mulong Du et al. Scientific Reports
- Urothelial cells undergo epithelial-to-mesenchymal transition after exposure to muscle invasive bladder cancer exosomes
- (2015) C A Franzen et al. Oncogenesis
- Circulating tumor cells detection has independent prognostic impact in high-risk non-muscle invasive bladder cancer
- (2014) Paola Gazzaniga et al. INTERNATIONAL JOURNAL OF CANCER
- Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA
- (2014) Alain R Thierry et al. NATURE MEDICINE
- AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
- (2014) Emmanuel S. Antonarakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular biomarkers for predicting outcomes in urothelial carcinoma of the bladder
- (2014) Nikhil Sapre et al. PATHOLOGY
- Quantitation of rare circulating tumor cells by folate receptor α ligand-targeted PCR in bladder transitional cell carcinoma and its potential diagnostic significance
- (2014) Fuming Qi et al. TUMOR BIOLOGY
- Predicting progression of bladder urothelial carcinoma using microRNA expression
- (2013) Eran Rosenberg et al. BJU INTERNATIONAL
- Extracellular MicroRNAs in Urologic Malignancies: Chances and Challenges
- (2013) Xiaoyi Huang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- miRNA Profiling Identifies Candidate miRNAs for Bladder Cancer Diagnosis and Clinical Outcome
- (2013) Nadine Ratert et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Aberrant expression of microRNAs in bladder cancer
- (2013) Hirofumi Yoshino et al. Nature Reviews Urology
- Detecting Circulating Tumor Cells: Current Challenges and New Trends
- (2013) Bin Hong et al. Theranostics
- Prognostic Role and HER2 Expression of Circulating Tumor Cells in Peripheral Blood of Patients Prior to Radical Cystectomy: A Prospective Study
- (2012) Michael Rink et al. EUROPEAN UROLOGY
- Current perspectives in bladder cancer management
- (2012) T. R. L. Griffiths et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Lack of progress in bladder cancer—what are the obstacles?
- (2012) Mark S. Soloway Nature Reviews Urology
- Integrated Genomic and Gene Expression Profiling Identifies Two Major Genomic Circuits in Urothelial Carcinoma
- (2012) David Lindgren et al. PLoS One
- The FGFR3 Mutation is Related to Favorable pT1 Bladder Cancer
- (2011) Bas W.G. van Rhijn et al. JOURNAL OF UROLOGY
- A Systematic Study of Gene Mutations in Urothelial Carcinoma; Inactivating Mutations in TSC2 and PIK3R1
- (2011) Gottfrid Sjödahl et al. PLoS One
- Detection of Circulating Tumor Cells in Metastatic and Clinically Localized Urothelial Carcinoma
- (2011) Thomas W. Flaig et al. UROLOGY
- Human epidermal growth factor receptor 2 expression status provides independent prognostic information in patients with urothelial carcinoma of the urinary bladder
- (2010) Christian Bolenz et al. BJU INTERNATIONAL
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- FGFR3, HRAS, KRAS, NRAS and PIK3CA Mutations in Bladder Cancer and Their Potential as Biomarkers for Surveillance and Therapy
- (2010) Lucie C. Kompier et al. PLoS One
- p53 expression in patients with advanced urothelial cancer of the urinary bladder
- (2009) Shahrokh F. Shariat et al. BJU INTERNATIONAL
- Spectrum of Phosphatidylinositol 3-Kinase Pathway Gene Alterations in Bladder Cancer
- (2009) F. M. Platt et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search